查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
年間契約型資訊服務
商品編碼
1646801

現行協議：為交易者提供強大情報 - 生命科學領域的關鍵交易和聯盟資料庫

Current Agreements: Powerful Intelligence for Dealmakers - Leading Deals and Alliances Database for the Life Sciences Sector
出版日期: 年間契約型資訊服務 | 出版商: Current Partnering | 英文

價格
簡介目錄

用於策略決策的綜合商業智慧

利用無與倫比的授權、併購和合作協議存取權限，推動您的業務決策

《當前協議》是生命科學產業專業人士尋求深入了解許可、合作、併購和其他策略交易的首要訂閱資料庫。我們的平台擁有超過 30 年的數千筆交易記錄的精心整理檔案，可提供全球生物製藥、醫療技術和診斷交易狀況的詳細資料驅動視圖。

為什麼要製定現行協議？

我們的平台提供實際合約條款、財務結構和策略交易組成部分的獨家存取權，使您能夠：

  • 以市場標準為基準 -深入了解行業特定的付款條款、特許權使用費結構和許可費用
  • 競爭策略分析 追蹤生物製藥、醫療技術和診斷領域的交易活動和策略聯盟
  • 發現新機會 - 發現積極參與許可、併購和研發合作的公司
  • 增強您的談判能力 -利用準確的交易數據來支持您的許可和投資策略
  • 維持業界領先 監控生命科學生態系中不斷發展的商業模式、交易結構和新的合作夥伴關係

誰從目前合約中受益？

我們的平台是商業策略、許可和企業發展專業人士的重要資源，其中包括：

  • C 級主管 根據全面的市場情報做出明智的策略決策
  • 業務開發與授權團隊 - 確定潛在合作夥伴並確定談判的基準交易條款
  • 技術轉移和智慧財產權經理透過了解標準行業慣例來獲得有利的許可協議
  • 投資分析師和財務顧問 -評估新夥伴關係的財務可行性和投資潛力
  • 法律與合規專業人士 - 存取詳細的合約條款和監管文件以支持盡職調查
  • 顧問和市場研究人員深入了解影響您所在產業的競爭格局和合約趨勢

現行協定的特性

每項現行協議交易記錄均採用經過驗證的來源資料構建，包括新聞稿、SEC 文件、公司披露和完整的協議文件，以提供完整透明的交易視圖。

每個交易設定檔包含：

  • 執行摘要 詳細概述主要涉及各方、交易類型及其策略意義。
  • 條款清單 一份結構化摘要，概述交易的關鍵組成部分，包括財務條款和義務。
  • 詳細分類 涵蓋產業、治療領域、地理、發展階段等多個參數。
  • 財務明細全面揭露預付款、里程碑、特許權使用費和收益分享協議
  • 監管備案和合約 - 查閱官方監管備案和完整合約（如有），以獲取更多法律信息

您值得信賴的經過驗證的高價值市場情報來源

我們致力於準確性、深度和透明度，確保現行協議中的每個數據點都經過徹底的來源和結構化，以實現最佳的易用性。

無論您是進行競爭分析、尋求許可協議還是為公司交易提供諮詢， "當前協議" 都能為您提供在快速發展的生命科學行業取得成功所需的競爭情報。

簡介目錄

Comprehensive Business Intelligence for Strategic Decision-Making

Empowering Business Decisions with Unparalleled Access to Licensing, M&A, and Partnership Agreements

Current Agreements is the premier subscription database for professionals in the life sciences industry seeking in-depth insights into licensing, collaboration, mergers & acquisitions, and other strategic transactions. With a meticulously curated archive of thousands of deal records spanning over three decades, our platform provides a detailed, data-driven view of the global biopharma, medtech, and diagnostics deal landscape.

Why Choose Current Agreements?

Our platform offers exclusive access to real-world contract terms, financial structures, and strategic deal components, allowing you to:

  • Benchmark Market Standards - Gain critical insights into industry-specific payment terms, royalty structures, and licensing fees.
  • Analyze Competitive Strategies - Track deal trends and strategic alliances across biopharma, medtech, and diagnostics sectors.
  • Identify New Opportunities - Discover companies actively engaging in licensing, M&A, and R&D collaborations within your area of interest.
  • Enhance Negotiation Power - Leverage precise deal data to support your licensing and investment strategies.
  • Stay Ahead of Industry Trends - Monitor evolving business models, deal structures, and emerging partnerships in the life sciences ecosystem.

Who Benefits from Current Agreements?

Our platform is an indispensable resource for professionals involved in business strategy, licensing, and corporate development, including:

  • C-Level Executives - Make informed strategic decisions based on comprehensive market intelligence.
  • Business Development & Licensing Teams - Identify potential partners and benchmark deal terms for negotiations.
  • Technology Transfer & Intellectual Property Managers - Secure advantageous licensing agreements by understanding standard industry practices.
  • Investment Analysts & Financial Advisors - Evaluate the financial viability and investment potential of emerging partnerships.
  • Legal & Compliance Experts - Access detailed contract provisions and regulatory filings to support due diligence efforts.
  • Consultants & Market Researchers - Gain deep insights into the competitive landscape and deal trends shaping the industry.

What Sets Current Agreements Apart?

Each deal record within Current Agreements is structured to provide a complete and transparent view of the transaction, with verified source material including press releases, SEC filings, company disclosures, and full contract documents.

Every deal profile includes:

  • Executive Summary - An overview detailing key parties, transaction type, and strategic significance.
  • Term Sheet - A structured summary outlining critical deal components, including financial terms and obligations.
  • Detailed Categorization - Indexed across multiple parameters such as industry sector, therapeutic focus, geographic region, and development stage.
  • Financial Breakdown - Comprehensive disclosure of upfront payments, milestones, royalties, and revenue-sharing agreements.
  • Regulatory Filings & Contract Documents - Access official regulatory submissions and, where available, full contract texts for an in-depth legal perspective.

A Trusted Source for Verified, High-Value Market Intelligence

Our commitment to accuracy, depth, and transparency ensures that every data point in Current Agreements is meticulously sourced and structured for optimal usability.

Whether you are conducting competitive analysis, pursuing licensing deals, or advising on corporate transactions, Current Agreements provides the critical intelligence necessary to drive success in the rapidly evolving life sciences industry.